Comparative Pharmacology
Head-to-head clinical analysis: EPICORT versus FLUONID.
Peer-Reviewed Evidence
Head-to-head clinical analysis: EPICORT versus FLUONID.
EPICORT vs FLUONID
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Epicort is a corticosteroid that exerts anti-inflammatory and immunosuppressive effects by binding to the glucocorticoid receptor, leading to modulation of gene expression and inhibition of phospholipase A2, thereby reducing prostaglandin and leukotriene synthesis.
Fluocinolone acetonide is a corticosteroid that binds to the glucocorticoid receptor, leading to inhibition of phospholipase A2, reduction of prostaglandin and leukotriene synthesis, and suppression of inflammatory mediators.
IV: 50 mg every 8 hours over 30 minutes.
0.05% cream or ointment applied topically to affected area once daily. Not to exceed 30 g per week.
None Documented
None Documented
Terminal half-life is 1.5–2 hours in adults; prolonged to 3–4 hours in severe hepatic impairment
3.5 hours; prolonged to 18–24 hours in severe hepatic impairment.
Renal (70% as unchanged drug and inactive metabolites), biliary/fecal (30%)
Renal 70% as unchanged drug, biliary/fecal 30% as metabolites.
Category C
Category C
Topical Corticosteroid
Topical Corticosteroid